Skip to results

Consultation end date

Consultation end date

Type

Type

Guidance programme

Showing 1 to 10 of 12

Guidance and quality standards in consultation
TitleConsultationTypeConsultation end date
Tafamidis for treating transthyretin amyloidosis with cardiomyopathy [ID6327]Draft guidanceTechnology appraisal guidance
Voxelotor for treating sickle cell disease [ID1403]Draft guidanceTechnology appraisal guidance
Ivosidenib with azacitidine for untreated acute myeloid leukaemia with an IDH1 R132 mutation [ID6198]Draft guidanceTechnology appraisal guidance
Pembrolizumab with chemotherapy for treating HER2-negative advanced gastric or gastro-oesophageal junction adenocarcinoma [ID4030]Draft guidanceTechnology appraisal guidance
Working alongside people and communities at NICE: a strategyNICE general consultationNICE general
Interim methods and processes for Late Stage Assessment (LSA) in HealthTechMethods / process manual consultationNICE process and methods
NICE integrated topic prioritisation and strategic principlesMethods / process manual consultationNICE process and methods
Methods and processes for including NICE technology appraisal recommendations in guidelinesMethods / process manual consultationNICE process and methods
Exagamglogene autotemcel for treating sickle cell disease [ID4016]Draft guidanceTechnology appraisal guidance
Endometriosis: diagnosis and management - diagnosing endometriosisDraft guidance consultationNICE guideline

Results per page

  1. 10
  2. 25
  3. 50
  4. All